Godrej Consumer Products LtdQ2 FY23

Godrej Consumer Products Ltd Q2 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹847P/E: 41.8Market Cap: ₹86.7K CrSector: Personal Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Long-term CAGR for the Soap category expected at 3% to 3.5%, with overall long-term category growth at 4% to 4.5%.
  • Consumption in Soap category believed stable despite recent volume declines due to inventory corrections; volume upside expected soon.
  • Single-digit volume growth anticipated in the second half of the fiscal year, driven by recovery in Household Insecticides, soap price normalization, and inventory correction in Indonesia.
  • Continued focus on market development via advertising, sampling, and accessibility expected to support volume growth.
  • Media investments have increased significantly (e.g., working media up 70%) to build categories like Air Care and Hair Color, driving future growth.
  • Indonesia expected to move close to flat in Q3 with very high growth possible in Q4 onward.
  • Household Insecticide volumes expected to return to normative levels after high COVID-19 related stocking in prior periods.
  • Overall, cautious optimism on volume and sales growth despite current inflation and market challenges.

See what Godrej Consumer Products Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

The document does not provide any specific information regarding current or future fundraising plans through debt or equity for Godrej Consumer Products Limited. There are mentions of operational strategies, margin management, cost control, investments in advertising, and business simplification, but no explicit details on raising capital through debt or equity issuance.

See what Godrej Consumer Products Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes
The transcript from Godrej Consumer Products Limited's November 08, 2022 call does not explicitly mention any current or future capex, capital investment, or strategic investment plans in detail. However, some relevant points related to investments can be summarized: - The company has increased media/advertising investments significantly (e.g., 70% increase in working media in Q2), focusing on market development in key categories like Air Care and Hair Color. - There is ongoing investment in market development initiatives, including pricing strategies, sampling, and distribution expansion in markets like Africa and Indonesia. - The company is investing in simplification efforts, such as SKU rationalization (25% cut in India) leading to improved cash flow and lower inventory. - Project Neo targets talent acquisition for long-term human capital development. - No specific capital expenditure or strategic investment figures or plans were disclosed. Thus, emphasis is more on market development, operational simplification, and talent acquisition rather than on large capital expenditure announcements.

Track Godrej Consumer Products Ltd — get its next earnings analysis in your feed

How does Godrej Consumer Products Ltd rank vs peers in Personal Products?

Pro feature
ThisGodrej Consumer Products Ltd
Rev 3Mar 3

How does Godrej Consumer Products Ltd rank in Personal Products?

Compare Godrej Consumer Products Ltd against every Personal Products company (Q2 FY23) on revenue, margins and earnings-call signals.

View Personal Products leaderboard →

Others in Personal Products this season

  • Anondita Medicare Ltd (Q3 FY26)

    Revenue from operations (Standalone) for H1 FY26: ₹4,765.06 lakh; H1 FY25: ₹2,497.06 lakh; YoY growth: 91% (Page 26) . Key investor presentation takeaways from

  • Bajaj Consumer (Q2 FY27)

    Q2 FY27 Net Sales Value: INR 332.7 Cr., up 27.3% YoY (Page 23) . Key investor presentation takeaways from Bajaj Consumer Care Ltd's Q2 FY27 investor presentatio

  • Anondita Medicare Ltd (Q4 FY26)

    Current unexecuted order book stands at approximately INR137 crores, which remains intact from the previous year. Key concall takeaways from Anondita Medicare…

  • Cupid Ltd (Q4 FY24)

    6,289 Lakhs, up 57.04% QoQ and 51.59% YoY from Rs. Key concall takeaways from Cupid Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →